Public Well being Expertise Firm Colour Well being introduced the appointment of Dr. Rebecca Miksad as Chief Medical Officer and Josh Sturm as Chief Income Officer.
Miksad is a medical oncologist and chief of the Excessive Danger Most cancers Genetics Clinic at Boston College College of Drugs. Beforehand, he held the place of senior medical director at a digital well being firm targeted on oncology. Flatiron Well being.
She is going to oversee the medical and scientific elements of Colour, together with the event of the digital most cancers clinic.
Sturm will deal with increasing Colour’s partnerships. He was beforehand a vp at a digital musculoskeletal firm Hinge Well being. He additionally served as vp at Surescripts and Cigna-owned on-line pharmacy and pharmacy profit supervisor Specific Scripts.
“Josh and Rebecca convey very important hands-on affected person and buyer relationship expertise that shall be invaluable in telling the story of what partnering with an organization like Colour can imply for each corporations and particular person sufferers,” mentioned Othman Laraki, CEO of Colour Well being, in a press release.
“Their experience is an embodiment of the work of Colour. They take particular person connections and translate them into well being advantages that attain 1000’s of individuals, permitting us to proceed to develop the attain and high quality of our companies for our purchasers.”
Digital startup for coronary heart and lung ailments Eko Well being provides Brent D. Lang to its board of administrators.
Lang is a former Olympic gold medalist and was chairman and CEO of Vocera Communications, main Vocera by its progress, IPO, and $3 billion acquisition by Stryker.
“Brent’s wealth of expertise in healthcare know-how and enterprise constructing, mixed with a deep dedication to enhancing affected person outcomes, makes him the proper match for Eko as we proceed to assist clinicians diagnose cardiopulmonary illness earlier and with higher accuracy,” mentioned Connor Landgraf, CEO of Eko Well being, in a press release. “We’re excited to welcome him to our Board of Administrators.”
Healthcare know-how firm Medtronic has employed Dr. James Porter as Chief Medical Officer for robotic surgical applied sciences and digital applied sciences inside its surgical enterprise, which is a part of the corporate’s Medical Surgical Portfolio.
Porter is a working towards urologic surgeon specializing in prostate, kidney most cancers and urinary tract reconstruction procedures. The corporate says he’s “a acknowledged chief within the international surgical neighborhood and one of many high 5 robotic surgical procedure practitioners within the U.S.”
He’s additionally medical director of robotic surgical procedure at Windfall Swedish in Seattle, Washington.
“Medtronic is privileged to welcome such a famend doctor to our firm and we sit up for Dr. Porter’s contributions as CMO of our Robotics and Digital divisions as we execute on our technique to scale and constantly enhance our capabilities to satisfy buyer wants and positively affect sufferers all over the world,” mentioned Rajit Kamal, common supervisor and vp of Robotic Surgical Applied sciences inside Medtronic’s Surgical division, in a press release.